Wandercraft

Wandercraft spent more than a decade building self-balancing medical exoskeletons — the Atalante X rehabilitation system (two U.S. FDA clearances, deployed in 100+ rehab centers) and the FDA-cleared Eve personal exoskeleton — before transferring that dynamic-balance technology into Calvin-40, its first industrial humanoid. Founded in Paris in 2012 and led by co-founder and CEO Matthieu Masselin, the company now runs dual headquarters in Paris and New York and counts Renault Group as both a strategic investor and its first humanoid customer.